188 related articles for article (PubMed ID: 17014268)
1. Altered responsivity to central administrations of corticotropin-releasing factor in rats with a history of opiate exposures.
Blatchford KE; Choi EA; McNally GP
Behav Neurosci; 2006 Oct; 120(5):1169-74. PubMed ID: 17014268
[TBL] [Abstract][Full Text] [Related]
2. Effects of corticotropin-releasing factor on prepulse inhibition of the acoustic startle response in two rat strains.
Conti LH; Murry JD; Ruiz MA; Printz MP
Psychopharmacology (Berl); 2002 May; 161(3):296-303. PubMed ID: 12021833
[TBL] [Abstract][Full Text] [Related]
3. Corticotropin-releasing factor and behavior.
Koob GF; Bloom FE
Fed Proc; 1985 Jan; 44(1 Pt 2):259-63. PubMed ID: 3871412
[TBL] [Abstract][Full Text] [Related]
4. Differential roles of corticotropin-releasing factor receptor subtypes 1 and 2 in opiate withdrawal and in relapse to opiate dependence.
Lu L; Liu D; Ceng X; Ma L
Eur J Neurosci; 2000 Dec; 12(12):4398-404. PubMed ID: 11122350
[TBL] [Abstract][Full Text] [Related]
5. Time-dependent induction of anxiogenic-like effects after central infusion of urocortin or corticotropin-releasing factor in the rat.
Spina MG; Merlo-Pich E; Akwa Y; Balducci C; Basso AM; Zorrilla EP; Britton KT; Rivier J; Vale WW; Koob GF
Psychopharmacology (Berl); 2002 Mar; 160(2):113-21. PubMed ID: 11875628
[TBL] [Abstract][Full Text] [Related]
6. Stimulant and anxiogenic effects of corticotropin releasing factor.
Koob GF; Thatcher-Britton K
Prog Clin Biol Res; 1985; 192():499-506. PubMed ID: 3878524
[TBL] [Abstract][Full Text] [Related]
7. A study of the lasting effects of cocaine pre-exposure on anxiety-like behaviors under baseline conditions and in response to central injections of corticotropin-releasing factor.
Erb S; Kayyali H; Romero K
Pharmacol Biochem Behav; 2006 Sep; 85(1):206-13. PubMed ID: 16987545
[TBL] [Abstract][Full Text] [Related]
8. Effects of neuropeptide Y and corticotropin-releasing factor on ethanol intake in Wistar rats: interaction with chronic ethanol exposure.
Thorsell A; Slawecki CJ; Ehlers CL
Behav Brain Res; 2005 Jun; 161(1):133-40. PubMed ID: 15904720
[TBL] [Abstract][Full Text] [Related]
9. Corticotropin releasing factor enhances attentional function as assessed by the five-choice serial reaction time task in rats.
Ohmura Y; Yamaguchi T; Futami Y; Togashi H; Izumi T; Matsumoto M; Yoshida T; Yoshioka M
Behav Brain Res; 2009 Mar; 198(2):429-33. PubMed ID: 19084036
[TBL] [Abstract][Full Text] [Related]
10. Differential dose effects of central CRF and effects of CRF astressin on pig behavior.
Salak-Johnson JL; Anderson DL; McGlone JJ
Physiol Behav; 2004 Oct; 83(1):143-50. PubMed ID: 15501501
[TBL] [Abstract][Full Text] [Related]
11. Corticotropin-releasing factor (CRF)-induced behaviors are modulated by intravenous administration of teneurin C-terminal associated peptide-1 (TCAP-1).
Al Chawaf A; Xu K; Tan L; Vaccarino FJ; Lovejoy DA; Rotzinger S
Peptides; 2007 Jul; 28(7):1406-15. PubMed ID: 17644218
[TBL] [Abstract][Full Text] [Related]
12. Impairment of dopaminergic system function after chronic treatment with corticotropin-releasing factor.
Izzo E; Sanna PP; Koob GF
Pharmacol Biochem Behav; 2005 Aug; 81(4):701-8. PubMed ID: 16005056
[TBL] [Abstract][Full Text] [Related]
13. Effects of urocortin 2 and 3 on motor activity and food intake in rats.
Ohata H; Shibasaki T
Peptides; 2004 Oct; 25(10):1703-9. PubMed ID: 15476937
[TBL] [Abstract][Full Text] [Related]
14. Intracerebroventricular administration of corticotropin-releasing factor antagonist attenuates arousal response accompanied by yawning behavior in rats.
Kita I; Kubota N; Yanagita S; Motoki C
Neurosci Lett; 2008 Mar; 433(3):205-8. PubMed ID: 18243550
[TBL] [Abstract][Full Text] [Related]
15. A role for neuromedin U in stress response.
Hanada R; Nakazato M; Murakami N; Sakihara S; Yoshimatsu H; Toshinai K; Hanada T; Suda T; Kangawa K; Matsukura S; Sakata T
Biochem Biophys Res Commun; 2001 Nov; 289(1):225-8. PubMed ID: 11708803
[TBL] [Abstract][Full Text] [Related]
16. A role for corticotropin-releasing factor in the long-term expression of behavioral sensitization to cocaine.
Erb S; Brown ZJ
Behav Brain Res; 2006 Sep; 172(2):360-4. PubMed ID: 16822557
[TBL] [Abstract][Full Text] [Related]
17. Corticotropin-releasing factor antagonist reduces activation of noradrenalin and serotonin neurons in the locus coeruleus and dorsal raphe in the arousal response accompanied by yawning behavior in rats.
Kubota N; Amemiya S; Motoki C; Otsuka T; Nishijima T; Kita I
Neurosci Res; 2012 Apr; 72(4):316-23. PubMed ID: 22285921
[TBL] [Abstract][Full Text] [Related]
18. Effects of ovine CRF injections into the dorsomedial, dorsolateral and lateral columns of the periaqueductal gray: a functional role for the dorsomedial column.
Borelli KG; Brandão ML
Horm Behav; 2008 Jan; 53(1):40-50. PubMed ID: 17920596
[TBL] [Abstract][Full Text] [Related]
19. Effects of the traditional Japanese medicine Unkei-to on the corticotropin-releasing factor-induced increase in locomotor activity.
Terawaki K; Koike K; Yuzurihara M; Kase Y; Takeda S; Aburada M; Murakami K; Ohno S; Suzuki N; Inoue M
Pharmacol Biochem Behav; 2004 Aug; 78(4):799-803. PubMed ID: 15301938
[TBL] [Abstract][Full Text] [Related]
20. Differential regulation of behavioral, genomic, and neuroendocrine responses by CRF infusions in rats.
Campbell BM; Morrison JL; Walker EL; Merchant KM
Pharmacol Biochem Behav; 2004 Mar; 77(3):447-55. PubMed ID: 15006454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
